Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

12.26USD
18 May 2018
Change (% chg)

$-0.13 (-1.05%)
Prev Close
$12.39
Open
$12.40
Day's High
$12.60
Day's Low
$12.24
Volume
123,805
Avg. Vol
223,780
52-wk High
$28.49
52-wk Low
$11.12

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 2.95
Market Cap(Mil.): $405.03
Shares Outstanding(Mil.): 32.69
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 223.30 32.53
EPS (TTM): -0.82 -- --
ROI: -51.22 -8.07 12.63
ROE: -52.83 -10.87 14.50

BRIEF-Cara Therapeutics Reports Q1 Loss Per Share $0.51

* CARA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Cara Therapeutics Reports Q4 Loss Per Share $0.43

* CARA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

15 Mar 2018

Earnings vs. Estimates